PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2018 Earnings Conference Call Transcript

Nov 05, 2018 • 04:30 pm ET


PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2018 Earnings Conference Call Transcript


Loading Event

Loading Transcript


Good afternoon, ladies and gentlemen, and welcome to the PTC Therapeutics Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. (Operator Instructions) As a reminder, this conference call is being recorded. I'd now like to turn the conference over to your host, Ms. Emily Hill, Head of Investor Relations. Ma'am, you may begin.

Emily Hill

Hello. Good afternoon, and thank you for joining us to discuss our 2018 third quarter corporate updates and financial results. Joining me on today's call is our CEO, Stuart Peltz; our Chief Operating Officer, Marcio Souza; and our Principal Financial Officer, Christine Utter. (Forward-Looking Cautionary Statements) We will disclose certain non-GAAP information during this call. Information regarding our use of GAAP and non-GAAP financial measures and a reconciliation of GAAP to non-GAAP is available in today's earnings release. With that, let me pass the call over to our CEO, Stuart Peltz.